EBR Systems Inc (ASX: EBR) Webcast Replay
17th August, 2022
EBR Systems Inc (ASX: EBR) is the world’s only provider of wireless, endocardial (inside the heart) pacing systems in a US$2.5 billion addressable market.
As a part of our ‘The Insiders: Meet the CEOs’ series, CEO John McCutcheon, provides valuable insights to the company, its key markets and industry, and future prospects.
Recorded on 17th August 2022 at 12pm (AEST).
Join the next The Insider: Meet the CEOs webcast
FEATURED SPEAKER
John McCutcheon
CEO - EBR Systems Inc (ASX: EBR)
EBR Systems provides safe, cost-effective and reliable therapies using wireless cardiac stimulation for millions of patients suffering from cardiac rhythm diseases. The company’s WiSE technology is the world’s only wireless, endocardial (inside the heart) pacing system in clinical use for stimulating the heart’s left ventricle (LV). The WiSE technology platform provides EBR with an initial addressable market of US$2.5 billion with rapid adoption of leadless devices supporting strong growth. The company’s technology is protected by over 97 issued patents globally and currently has no direct competitors known to be developing leadless LV pacing technology for Cardiac Resynchronisation Therapy (CRT).
